These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7922006)

  • 1. Gene marking to improve the outcome of autologous bone marrow transplantation.
    Brenner MK; Rill DR
    J Hematother; 1994; 3(1):33-6. PubMed ID: 7922006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene marking to improve the outcome of autologous bone marrow transplantation.
    Brenner MK; Rill DR
    Prog Clin Biol Res; 1994; 389():587-91. PubMed ID: 7700924
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of gene marking in bone marrow transplantation.
    Heslop HE; Rooney CM; Rill DR; Krance RA; Brenner MK
    Cancer Detect Prev; 1996; 20(2):108-13. PubMed ID: 8706035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene marking and autologous bone marrow transplantation.
    Brenner MK; Rill DR; Moen RC; Krance RA; Heslop HE; Mirro J; Anderson WF; Ihle JN
    Ann N Y Acad Sci; 1994 May; 716():204-14; discussion 214-5, 225-7. PubMed ID: 8024195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients.
    Brenner MK; Rill DR; Holladay MS; Heslop HE; Moen RC; Buschle M; Krance RA; Santana VM; Anderson WF; Ihle JN
    Lancet; 1993 Nov; 342(8880):1134-7. PubMed ID: 7901474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral gene transfer in autologous bone marrow transplantation for adult acute leukemia.
    Cornetta K; Srour EF; Moore A; Davidson A; Broun ER; Hromas R; Moen RC; Morgan RA; Rubin L; Anderson WF; Hoffman R; Tricot G
    Hum Gene Ther; 1996 Jul; 7(11):1323-9. PubMed ID: 8818719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrovirus-mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation.
    Rill DR; Buschle M; Foreman NK; Bartholomew C; Moen RC; Santana VM; Ihle JN; Brenner MK
    Hum Gene Ther; 1992 Apr; 3(2):129-36. PubMed ID: 1391032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells.
    Rill DR; Santana VM; Roberts WM; Nilson T; Bowman LC; Krance RA; Heslop HE; Moen RC; Ihle JN; Brenner MK
    Blood; 1994 Jul; 84(2):380-3. PubMed ID: 8025266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.
    Brenner MK; Rill DR; Moen RC; Krance RA; Mirro J; Anderson WF; Ihle JN
    Lancet; 1993 Jan; 341(8837):85-6. PubMed ID: 8093407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of marker genes to investigate the mechanism of relapse and the effect of bone marrow purging in autologous transplantation for stage D neuroblastoma.
    Hum Gene Ther; 1993 Dec; 4(6):809-20. PubMed ID: 8186293
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of the efficacy of purging by using gene marked autologous marrow transplantation for children with AML in first complete remission.
    Brenner M; Krance R; Heslop HE; Santana V; Ihle J; Ribeiro R; Roberts WM; Mahmoud H; Boyett J; Moen RC
    Hum Gene Ther; 1994 Apr; 5(4):481-99. PubMed ID: 8049305
    [No Abstract]   [Full Text] [Related]  

  • 12. A phase I trial of high-dose carboplatin and etoposide with autologous marrow support for treatment of stage D neuroblastoma in first remission: use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse.
    Hum Gene Ther; 1991; 2(3):257-72. PubMed ID: 1661172
    [No Abstract]   [Full Text] [Related]  

  • 13. A phase I trial of high-dose carboplatin and etoposide with autologous marrow support for treatment of relapse/refractory neuroblastoma without apparent bone marrow involvement: use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse.
    Hum Gene Ther; 1991; 2(3):273-86. PubMed ID: 1661173
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene transfer for the therapy of hematologic malignancy.
    Heslop HE; Roskrow M
    Curr Opin Hematol; 1995 Nov; 2(6):417-22. PubMed ID: 9372030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer.
    Rill DR; Moen RC; Buschle M; Bartholomew C; Foreman NK; Mirro J; Krance RA; Ihle JN; Brenner MK
    Blood; 1992 May; 79(10):2694-700. PubMed ID: 1316784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up.
    Ball ED; Wilson J; Phelps V; Neudorf S
    Bone Marrow Transplant; 2000 Apr; 25(8):823-9. PubMed ID: 10808202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
    Alici E; Björkstrand B; Treschow A; Aints A; Smith CI; Gahrton G; Dilber MS
    Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune reconstitution after autologous purged bone marrow transplantation in children.
    Kamani N; Kattamis A; Carroll A; Campbell D; Bunin N
    J Pediatr Hematol Oncol; 2000; 22(1):13-9. PubMed ID: 10695816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of retroviral transduction in chronic myelogenous leukemia.
    Claxton D; Suh SP; Filaccio M; Ellerson D; Gaozza E; Andersson B; Brenner M; Reading C; Feinberg A; Moen R
    Hum Gene Ther; 1991; 2(4):317-21. PubMed ID: 1665348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.
    Cassileth PA; Harrington DP; Appelbaum FR; Lazarus HM; Rowe JM; Paietta E; Willman C; Hurd DD; Bennett JM; Blume KG; Head DR; Wiernik PH
    N Engl J Med; 1998 Dec; 339(23):1649-56. PubMed ID: 9834301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.